• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿激酶受体介导间充质干细胞的动员、迁移和分化。

Urokinase receptor mediates mobilization, migration, and differentiation of mesenchymal stem cells.

机构信息

Department of Nephrology, Hannover Medical School, Hannover D-30625, Germany.

出版信息

Cardiovasc Res. 2011 Apr 1;90(1):113-21. doi: 10.1093/cvr/cvq362. Epub 2010 Nov 18.

DOI:10.1093/cvr/cvq362
PMID:21088115
Abstract

AIMS

Multipotent mesenchymal stem cells (MSCs) have regenerative properties and are recognized as putative players in the pathogenesis of cardiovascular diseases. The underlying molecular mechanisms remain, however, sparsely explored. Our study was designed to elucidate a probable role for the multifunctional urokinase (uPA)/urokinase receptor (uPAR) system in MSC regulation. Though uPAR has been implicated in a broad spectrum of pathophysiological processes, nothing is known about uPAR in MSCs.

METHODS AND RESULTS

uPAR was required to mobilize MSCs from the bone marrow (BM) of mice stimulated with granulocyte colony-stimulating factor (G-CSF) in vivo. An insignificant amount of MSCs was mobilized in uPAR(-/-) C57BL/6J mice, whereas in wild-type animals G-CSF induced an eight-fold increase of mobilized MSCs. uPAR(-/-) mice revealed up-regulated expression of G-CSF and stromal cell-derived factor 1 (CXCR4) receptors in BM. uPAR down-regulation leads to inhibition of human MSC migration, as shown in different migration assays. uPAR down- or up-regulation resulted in inhibition or stimulation of MSC differentiation into vascular smooth muscle cells (VSMCs) correspondingly, as monitored by changes in cell morphology and expression of specific marker proteins. Injection of fluorescently labelled MSCs in non-obese diabetic/severe combined immunodeficiency (NOD/SCID) mice after femoral artery wire injury demonstrated impaired engraftment of uPAR-deficient MSCs at the place of injury.

CONCLUSIONS

These data suggest a multifaceted function of uPAR in MSC biology contributing to vascular repair. uPAR might guide and control the trafficking of MSCs to the vascular wall in response to injury or ischaemia and their differentiation towards functional VSMCs at the site of arterial injury.

摘要

目的

多能间充质干细胞(MSCs)具有再生特性,被认为是心血管疾病发病机制中的潜在参与者。然而,其潜在的分子机制仍知之甚少。我们的研究旨在阐明多功能尿激酶(uPA)/尿激酶受体(uPAR)系统在 MSC 调节中的可能作用。虽然 uPAR 已被牵连到广泛的病理生理过程中,但在 MSCs 中尚未了解 uPAR。

方法和结果

体内用粒细胞集落刺激因子(G-CSF)刺激小鼠的骨髓(BM)时,uPAR 被需要来动员 MSCs。在 uPAR(-/-)C57BL/6J 小鼠中动员的 MSCs 数量很少,而在野生型动物中,G-CSF 诱导动员的 MSCs 增加了八倍。uPAR(-/-)小鼠显示出 BM 中 G-CSF 和基质细胞衍生因子 1(CXCR4)受体的上调表达。uPAR 下调导致人 MSC 迁移抑制,如不同迁移测定所示。uPAR 下调或上调导致 MSC 相应地分化为血管平滑肌细胞(VSMCs)的抑制或刺激,如细胞形态和特定标记蛋白的表达变化所监测到的。在股动脉线损伤后,将荧光标记的 MSC 注射到非肥胖型糖尿病/严重联合免疫缺陷(NOD/SCID)小鼠中,表明在损伤部位受损的 uPAR 缺陷 MSC 的植入受损。

结论

这些数据表明 uPAR 在 MSC 生物学中具有多方面的功能,有助于血管修复。uPAR 可能指导和控制 MSC 向血管壁的迁移,以响应损伤或缺血,以及它们在动脉损伤部位向功能性 VSMCs 的分化。

相似文献

1
Urokinase receptor mediates mobilization, migration, and differentiation of mesenchymal stem cells.尿激酶受体介导间充质干细胞的动员、迁移和分化。
Cardiovasc Res. 2011 Apr 1;90(1):113-21. doi: 10.1093/cvr/cvq362. Epub 2010 Nov 18.
2
Urokinase-receptor-mediated phenotypic changes in vascular smooth muscle cells require the involvement of membrane rafts.尿激酶受体介导的血管平滑肌细胞表型变化需要脂筏的参与。
Biochem J. 2009 Oct 12;423(3):343-51. doi: 10.1042/BJ20090447.
3
Role of vessel wall and bone marrow syndecan-4 in neointimal hyperplasia: the plot thickens.血管壁和骨髓中的Syndecan-4在新生内膜增生中的作用:情况愈发复杂。
Arterioscler Thromb Vasc Biol. 2011 May;31(5):952-3. doi: 10.1161/ATVBAHA.111.225557.
4
Urokinase receptor associates with myocardin to control vascular smooth muscle cells phenotype in vascular disease.尿激酶受体与肌球蛋白结合,以控制血管疾病中的血管平滑肌细胞表型。
Arterioscler Thromb Vasc Biol. 2012 Jan;32(1):110-22. doi: 10.1161/ATVBAHA.111.234369. Epub 2011 Nov 10.
5
Late outgrowth endothelial cells derived from Wharton jelly in human umbilical cord reduce neointimal formation after vascular injury: involvement of pigment epithelium-derived factor.人脐带华通胶来源的晚期生长内皮细胞可减少血管损伤后的内膜增生:色素上皮衍生因子的作用
Arterioscler Thromb Vasc Biol. 2009 Jun;29(6):816-22. doi: 10.1161/ATVBAHA.109.184739. Epub 2009 Apr 2.
6
The interferon stimulated gene 12 inactivates vasculoprotective functions of NR4A nuclear receptors.干扰素刺激基因 12 使 NR4A 核受体的血管保护功能失活。
Circ Res. 2012 Apr 13;110(8):e50-63. doi: 10.1161/CIRCRESAHA.111.258814. Epub 2012 Mar 15.
7
In vivo activity of the cleaved form of soluble urokinase receptor: a new hematopoietic stem/progenitor cell mobilizer.可溶性尿激酶受体裂解形式的体内活性:一种新型造血干/祖细胞动员剂。
Cancer Res. 2006 Nov 15;66(22):10885-90. doi: 10.1158/0008-5472.CAN-06-1311.
8
oxLDL induces inflammatory responses in vascular smooth muscle cells via urokinase receptor association with CD36 and TLR4.氧化低密度脂蛋白通过尿激酶受体与 CD36 和 TLR4 的结合诱导血管平滑肌细胞的炎症反应。
J Mol Cell Cardiol. 2014 Jan;66:72-82. doi: 10.1016/j.yjmcc.2013.11.005. Epub 2013 Nov 14.
9
The tyrosine phosphatase SHP-2 controls urokinase-dependent signaling and functions in human vascular smooth muscle cells.酪氨酸磷酸酶SHP-2在人血管平滑肌细胞中控制尿激酶依赖性信号传导及功能。
Exp Cell Res. 2009 Apr 1;315(6):1029-39. doi: 10.1016/j.yexcr.2008.12.011. Epub 2008 Dec 25.
10
Urokinase receptor mediates doxorubicin-induced vascular smooth muscle cell senescence via proteasomal degradation of TRF2.尿激酶受体通过蛋白酶体降解TRF2介导阿霉素诱导的血管平滑肌细胞衰老。
J Vasc Res. 2013;50(2):109-23. doi: 10.1159/000343000. Epub 2012 Nov 21.

引用本文的文献

1
Bone morphogenetic protein-4 induced matrix turnover and osteogenic differentiation-related molecules of stem cells from apical papilla and its associated ALK/Smad signaling.骨形态发生蛋白-4诱导根尖乳头干细胞的基质更新和成骨分化相关分子及其相关的ALK/Smad信号通路
J Dent Sci. 2025 Jan;20(1):646-659. doi: 10.1016/j.jds.2024.11.002. Epub 2024 Nov 17.
2
Engineered Mesenchymal Stem Cells as Treatment for Cancers: Opportunities, Clinical Applications and Challenges.工程化间充质干细胞用于癌症治疗:机遇、临床应用与挑战
Malays J Med Sci. 2024 Oct;31(5):56-82. doi: 10.21315/mjms2024.31.5.5. Epub 2024 Oct 8.
3
Platelet-Rich Plasma Power-Mix Gel (ppm)-An Orthobiologic Optimization Protocol Rich in Growth Factors and Fibrin.
富含血小板血浆动力混合凝胶(ppm)——一种富含生长因子和纤维蛋白的生物优化方案
Gels. 2023 Jul 7;9(7):553. doi: 10.3390/gels9070553.
4
bFGF stimulated plasminogen activation factors, but inhibited alkaline phosphatase and SPARC in stem cells from apical Papilla: Involvement of MEK/ERK, TAK1 and p38 signaling.bFGF 刺激顶端牙髓干细胞中的纤溶酶原激活因子,但抑制碱性磷酸酶和 SPARC:涉及 MEK/ERK、TAK1 和 p38 信号通路。
J Adv Res. 2022 Sep;40:95-107. doi: 10.1016/j.jare.2021.12.006. Epub 2021 Dec 28.
5
Modulation of Cellular Function by the Urokinase Receptor Signalling: A Mechanistic View.尿激酶受体信号传导对细胞功能的调节:一种机制性观点
Front Cell Dev Biol. 2022 Apr 8;10:818616. doi: 10.3389/fcell.2022.818616. eCollection 2022.
6
Role of extracellular vesicles from adipose tissue- and bone marrow-mesenchymal stromal cells in endothelial proliferation and chondrogenesis.脂肪组织和骨髓间充质干细胞来源的细胞外囊泡在血管内皮细胞增殖和软骨生成中的作用。
Stem Cells Transl Med. 2021 Dec;10(12):1680-1695. doi: 10.1002/sctm.21-0107. Epub 2021 Sep 4.
7
Bone Marrow Aspirate Matrix: A Convenient Ally in Regenerative Medicine.骨髓抽吸基质:再生医学的便利盟友。
Int J Mol Sci. 2021 Mar 9;22(5):2762. doi: 10.3390/ijms22052762.
8
P2 Receptors Influence hMSCs Differentiation towards Endothelial Cell and Smooth Muscle Cell Lineages.P2 受体影响骨髓间充质干细胞向血管内皮细胞和平滑肌细胞谱系的分化。
Int J Mol Sci. 2020 Aug 27;21(17):6210. doi: 10.3390/ijms21176210.
9
Molecular imaging of the urokinase plasminogen activator receptor: opportunities beyond cancer.尿激酶型纤溶酶原激活物受体的分子成像:癌症之外的机遇
EJNMMI Res. 2020 Jul 28;10(1):87. doi: 10.1186/s13550-020-00673-7.
10
The Osteosarcoma Microenvironment: A Complex But Targetable Ecosystem.成骨肉瘤微环境:一个复杂但可靶向的生态系统。
Cells. 2020 Apr 15;9(4):976. doi: 10.3390/cells9040976.